Freenome

Decision/Risk AnalysisWebsite

Developer of a multi-omics platform designed to detect cancer at an early stage through a routine blood draw. The company's platform uses a proprietary algorithm method that aims to reinvent disease m...

Decision/Risk Analysis
Healthcare
Brisbane, CA, United States
Founded 2014
392 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$1.4B
Last Round
PIPE
Dec 2025

Get the full picture

Create a free account to unlock Freenome's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required